Detalhe da pesquisa
1.
Two-Year Results of the Phase 3 Randomized Controlled Study of Abicipar in Neovascular Age-Related Macular Degeneration.
Ophthalmology
; 128(7): 1027-1038, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33221326
2.
Phase 3, Randomized Study Comparing Intracameral Bimatoprost Implant 15 µg and Selective Laser Trabeculectomy in Patients with Open-Angle Glaucoma or Ocular Hypertension.
Clin Ophthalmol
; 17: 3023-3036, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37850049
3.
Single Administration of Bimatoprost Implant: Effects on 24-Hour Intraocular Pressure and 1-Year Outcomes.
Ophthalmol Glaucoma
; 6(6): 599-608, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37343625
4.
Randomized Phase IIb Study of Brimonidine Drug Delivery System Generation 2 for Geographic Atrophy in Age-Related Macular Degeneration.
Ophthalmol Retina
; 7(7): 573-585, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-36906177
5.
Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration.
J Ocul Pharmacol Ther
; 34(10): 700-709, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30412448